Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.

G Forouhi, Nita; Koulman, Albert; J Sharp, Stephen; Imamura, Fumiaki; Kröger, Janine; B Schulze, Matthias; L Crowe, Francesca; María Huerta, José; Guevara, Marcela; W J Beulens, Joline; J van Woudenbergh, Geertruida; Wang, Laura; Summerhill, Keith; L Griffin, Julian; J M Feskens, Edith; Amiano, Pilar; Boeing, Heiner; Clavel-Chapelon, Françoise; Dartois, Laureen; Fagherazzi, Guy; W Franks, Paul; Gonzalez, Carlos; Uhre Jakobsen, Marianne; Kaaks, Rudolf; J Key, Timothy; Khaw, Kay-Tee; Kühn, Tilman; Mattiello, Amalia; M Nilsson, Peter; Overvad, Kim; Pala, Valeria; Palli, Domenico; Ramón Quirós, J; Rolandsson, Olov; Roswall, Nina; Sacerdote, Carlotta; Sánchez, María-José; Slimani, Nadia; M W Spijkerman, Annemieke; Tjonneland, Anne; Tormo, Maria-José; Tumino, Rosario; L van der A, Daphne; T van der Schouw, Yvonne; Langenberg, Claudia; Riboli, Elio; J Wareham, Nicholas

doi:10.1016/s2213-8587(14)70146-9

Public

Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.

Published in The lancet. Diabetes & endocrinology • Oct 1, 2014

NobleIDark:/48914/w1/20260517/8A205617Record on NobleID

Authors:

Nita G Forouhi

,

Albert Koulman

,

Stephen J Sharp

Abstract

BACKGROUND: Conflicting evidence exists regarding the association between saturated fatty acids (SFAs) and type 2 diabetes. In this longitudinal case-cohort study, we aimed to investigate the prospective associations between objectively measured individual plasma phospholipid SFAs and incident type ...

Discussions